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Abstract 
 
Abstract 
The prevalence of overweight and obesity is increasing in all age groups and continents. The 
leading cause is nutritional intake of high amounts of fat. Obesity is a major risk factor for 
endocrine and cardiovascular diseases like high blood pressure, insulin resistance and the 
subsequent development of atherosclerosis. Childhood obesity affects cardiac function instantly and 
is a risk factor for coronary heart disease and unfavorable metabolic changes in adulthood, 
independent from body weight at that time. The objective of this study was to investigate changes in 
vascular reactivity of the aorta and carotid arteries of young mice in response to high dietary fat 
intake. 4 weeks old C57BL/6J mice were either fed a high-fat diet (Obese group) or standard rodent 
chow (Control group) for 30 weeks. Vascular responses to phenylephrine (PE) and acetylcholine 
(ACh) were investigated in aortic and carotid artery rings of these animals ex vivo, in absence and 
presence of nitric oxide (NO) and endoperoxides. Compared to the Control group, the mice of the 
Obese group showed glucose intolerance, greater weight gain and altered responses to vasoactive 
agents. The contractile response to PE was enhanced and was further augmented by inhibition of 
NO production in the aorta of the Obese group, whereas in the carotid artery of the Obese group and 
in the Control group the contraction remained unaffected. Relaxations to ACh were not diminished 
in the Obese group. In untreated vessels, contractions to high concentrations of ACh were observed 
in the carotid artery. They were abolished by an unspecific cyclooxygenase-inhibitor. Inhibition of 
endogenous NO production abrogated endothelium-dependent relaxations to ACh and contractile 
responses were observed in all vessels. These endothelium-dependent contractions were stronger 
and started at lower concentrations in the carotid artery and were increased by obesity. In 
conclusion, the findings of the present study suggest that a high dietary fat intake leads to weight 
gain, glucose intolerance and enhanced vascular contractile response in adolescent mice. The 
heterogenous diet-induced changes indicate selective effects on different vascular beds. These 
findings may be important to understand the variability in the onset and progression of vascular 
diseases in different vascular beds in obese patients and to develop efficient therapeutic strategies. 
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List of Abbreviations  
ACh Acetylcholine 
AT1B Angiotensin Receptor, subgroup 1B 
ATP Adenosine Triphosphate 
AUC Area Under the Curve 
BMI Body Mass Index 
cGMP Cyclic Guanosine Monophosphate 
COX Cyclooxygenase, subgroups COX-1, COX-2 
DAG Diacylglycerol 
EDCF Endothelium-Derived Contracting Factor 
EDHF Endothelium-Derived Hyperpolarization Factor 
eNOS endothelial Nitric Oxide Synthase 
ETA Endothelin Receptor, subgroup A 
HFD High-Fat Diet (57% kcal of lipids) 
iNOS inflammatory Nitric Oxide Synthase 
IP3 Inositol Triphosphate 
KCl Potassium Chloride 
L-NAME  NG-Nitro-L-Arginine Methylester 
M3 Muscarinic Receptor, subgroup 3 
Meclo Meclofenamate 
nNOS neuronal Nitric Oxide Synthase 
NO Nitric Oxide 
NOS Nitric Oxide Synthase (subgroups eNOS, nNOS, iNOS) 
PE Phenylephrine 
PIP2 Phosphatidyl-Inositol-Biphosphate 
PKC Proteinkinase C 
PPARγ  Peroxisome Proliferator-Activated Receptor 
ROS Reactive Oxygen Species  
WHO World Health Organisation 
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1. Introduction 
1.1. Obesity  
1.1.1.  Prevalence  
Obesity is a disease affecting a large number of people and has become an important healthcare 
issue over the last few decades. It is defined as a body mass index (BMI) being greater than 30,1 
while the range between 25 and 30 counts as overweight. The prevalence of overweight and obesity 
is still increasing and affects all age levels in developed as well as in developing countries.2-6 
Instead of using overweight and related body mass index (BMI) as indicators for the prognosis of 
pathological changes, recent studies emphasize that the distribution of the body fat is crucial for 
accurate estimations. In this context the term of visceral obesity measured by the waist-
circumference has been coined and is used as a prediction value.7 Like in the rest of Europe, the 
number of individuals being overweight or obese is increasing in Switzerland.8,9 National data from 
1999 shows a prevalence of overweight and obesity of 21.8% and 4.5% for women and 39.2% and 
5.8% for men.10 For both combined, an increase from 44% to 59% for men and from 24% to 37% 
for women was reported in 2005.8 Even though prevention campaigns have been launched in 
several countries, prognoses for the prevalence indicate clear upward trends for overweight and 
obesity in the future.10-12 The prevalence of cardiovascular disease as a consequence of obesity is 
expected to increase by 5%, leading to an estimate of 16%, by 2020.13 
 
1.1.2. Childhood Obesity 
Obesity in childhood is becoming increasingly prevalent.14 The presence of obesity or the related 
metabolic syndrome at young age is a significant predictor of cardiovascular disease and other 
health problems in adulthood.15-17 Long-term consequences of pediatric obesity are independent 
from body weight as an adult and include higher risk for early death.18,19 Like in adulthood, 
overweight in childhood is related to various pathologic states such as alterations in endothelium-
Introduction 
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dependent dilation and increased intima-media thickening.20,21 High blood pressure, impaired 
glucose tolerance, insulin resistance and endothelial dysfunction can be observed in arteries of 
overweight children and adolescents and similarly in animals fed a high-fat diet.20-23 Although 
functional or macroscopic vascular changes in obese children are mostly asymptomatic, they can 
affect cardiac function in children.24,25 Besides the vasculature, other organs and systems can be 
affected and orthopedic, neurologic, pulmonary and gastroenterologic problems can arise.18,25,26 To 
protect children efficiently from these obesity-associated health problems, it is important to improve 
the efficacy preventory measures.27 
 
1.1.3. Consequences of Obesity  
1.1.3.1. Metabolic Syndrome  
Obesity is a complex disorder, genetic and environmental factors contributing to its 
development.28,29 Since the genetic background of the human race seems not to have changed 
dramatically over the last few decades, factors like decreased physical activity and excessive 
nutrition are suspected to play a crucial role.30 It is associated with other cardiovascular risk factors, 
such as insulin resistance and subsequent development of type II diabetes.31 Other diseases 
associated with overweight and obesity are high blood pressure, high cholesterol levels and 
dyslipidemia,  altogether forming a cluster of symptoms known as the metabolic syndrome.4,32,33 
The syndrome has been the topic of numerous studies since it was established in 1977 and 
definitions for the diagnosis of the metabolic syndrome have been adapted by various organizations, 
including the World Health Organization (WHO).32,34  It is widely accepted that the metabolic 
syndrome is associated with a significantly elevated cardiovascular and metabolic risk.35,36 
Cardiovascular disease not only affects the quality of life and morbidity, but is the principal cause 
of death in the United States of America, Europe, and major parts of Asia.37  
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1.1.3.2. Economic Aspects 
The treatment of obesity and the associated cardiovascular diseases are responsible for estimated 2 
to 6.8% of the health care expenses and thus is a heavy burden for the health care system.38 These 
data do not only represent the situation in Canada and the USA, where the prevalence of overweight 
and obesity is generally higher than in  European countries, but the high impact has similarly been 
reported for Switzerland.38-40 In line with the growing prevalence of obesity, the economic impact is 
expected to increase dramatically in the future.12,39 
 
1.1.3.3. Effect of Nutritional Change on Vascular Function 
Obesity as well as atherosclerosis and hypertension are defined as chronic diseases.41 Various risk 
factors such as overweight,42 cigarette smoking,43 diabetes mellitus,44 high blood pressure and 
elevated blood lipid levels45 lead to pathologic changes in the endothelium's major functions like the 
homeostasis of blood flow and the secretion of tone- and coagulation-modulating agents. They are 
related to each other as obesity can cause changes in vascular function and, as a macroscopic 
equivalent, atherosclerotic lesions can occur. Changes on molecular level are multifaceted and 
precede macroscopic, sonographic and even microscopic changes of atherosclerosis.46 Metastudies 
show that a diet containing high amounts of fat increases the likelihood of gain in body mass in 
rodents and humans.47 The outweighing part (89%) of this weight gain is due to fat accretion.48 In 
1983, Anitschkow and Chalatow in a seminal work have shown that animals (rabbits and guinea 
pigs) fed with egg yolk developed hypertrophy of the intima and infiltration of fatty substances in 
the aorta.49 In the subsequent series of experiments, they extracted cholesterol as the responsible 
agent.49 This substantiates the hypothesis that not only the amount of fat but also its biochemical 
origin influences the consequences on vasculature.50 Although the composition of dietary fat can 
influence the severity of weight gain and associated vascular changes, it is reported that the amount 
of dietary fat is of higher importance.50 Increased dietary fat intake induces insulin resistance,51 
dyslipidemia and hyperleptinemia,52 salt sensitivity,53 increased oxidative stress levels54 and high 
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blood pressure.53 These morbidities lead to endothelial dysfunction and enhance vasoconstriction.55 
The development of atherosclerosis as a complex disorder was first formulated as the hypothesis of 
"response-to-injury".56 The model was adapted later leading to the characterization of 
atherosclerosis as an inflammatory disease.57 Large prospective studies showed that the extent of 
atherosclerotic lesions in the coronary arteries correlates with the grade of obesity in men.24,58  
 
1.1.3.4. Role of Vasoactive Molecules  
The endothelium plays an important role in the regulation of blood flow and metabolic processes 
taking place in the vascular wall.59 By synthesizing and secreting various vasoactive substances, 
endothelial cells are involved in controlling the tone of smooth muscle cells, platelet aggregation, 
leukocyte migration, inflammatory processes and response to circulating substances.60-62 Modulation 
of the diameter of the vessel is the result of a complex interaction between vasoconstricting and 
vasodilating agents. This balance is disturbed in obesity and vasoconstriction is enhanced. Some of 
the factors involved in the regulation are released by the endothelium itself, others are delivered by 
the blood flow. The most important vasoconstrictors are endothelin-1,63 angiotensin II,64 
thromboxane A265 and α-adrenergic ligands like epinephrine. In obesity, besides an increase in the 
synthesis of molecules effecting contraction, a parallel increase in the expression of the interacting 
receptor such as angiotensin- (AT1B) and endothelin-receptors (ETA) is observed.21 Furthermore, 
high-fat diet increases the level of reactive oxygen species (ROS).66 These molecules can directly 
inactivate nitric oxide (NO), thereby inhibiting vasodilation.54,67 High levels of free fatty acids 
observed in obesity alter the vascular reactivity by enhancing α1 adrenoceptor-mediated 
contractions in vascular smooth muscle cells.68 Under certain circumstances, Acetylcholine (ACh) 
has vasoconstrictor effects generating endothelium-derived contracting factors (EDCFs) via the 
action of cyclooxygenase (COX). Vasodilatory factors include prostacycline (prostaglandine I2),69 
ACh,59 NO,70 bradykinin71 and the endothelium-derived hyperpolarization factor (EDHF).72 
Prostacycline leads to vasodilation by activating adenosine triphosphate (ATP)-sensitive potassium 
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channels.73 ACh activates endothelium-dependent NO-synthesis74 and bradykinin leads to the 
formation of various vasodilating factors including NO, EDHF and prostanoids. Although the 
existence of an EDHF has been demonstrated in different arteries and species, the physical 
equivalent is still under investigation. Factors that probably play a role are potassium ions, 
hydrogen peroxide and epoxyeicosatrienoic acids.75 Besides these vasoactive substances, several 
growth factors and enzymes like proteases play a role in the vascular remodeling leading to 
atherosclerosis.76 
 
1.1.4. Vasoactive Agents 
1.1.4.1. Effects of Phenylephrine  
Phenylephrine (PE) is a synthetic drug derived from epinephrine. Besides the 3-hydroxy-group, it is 
structurally identical with epinephrine, the sympato-mimetic endogenous stress-hormone secreted 
by the adrenal gland.77 PE is a selective agonist on adrenergic α-receptors.78,79 The group of 
adrenergic receptors can be divided into two main groups, α (α1, α2) and β (β1, β2, β3).80,81 The 
expression pattern, intracellular pathways and thus downstream effects differ between the 
subtypes.82 One important action of adrenergic receptors is modulating vessel tone and thereby 
systemic blood pressure. While activation of α1- and β2-receptors mediates vasoconstriction (α1 via 
phospholipase C [PLC], β2 by inactivating adenylyl-cyclase), binding to α2-receptors (activating 
adenylyl-cyclase) leads to vasodilation.83 The activation of the G-protein coupled α1-receptors 
activates PLC, which leads to the cleavage of phosphatidyl-inositol-biphosphate (PIP2) into the 
second messengers inositol-triphosphate (IP3) and diacylglycerol (DAG).84 IP3 effectuates the 
release of calcium from the sarcoplasmatic reticulum and activation of proteinkinase C (PKC), 
causing depolarisation and therefore contraction of the vascular smooth muscle cell.85 This pathway 
is known as the phosphatidyl-inositol-pathway.  
The contractile response of the smooth muscle cells following the exposure to PE occurs in healthy 
as well as in endothelium-denudated arteries and is therefore endothelium-independent.86 
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Endothelial denudation can even increase the vasoconstrictor reaction up to two-fold.87 This finding 
can be explained by the localisation of PE-receptors directly on smooth muscle cells as well as on 
the cell membrane of endothelial cells, where they have inverse effects on the vascular tone by 
causing vasodilation.88 Furthermore, the PE-mediated effects can be modulated by the expression of 
its receptors.21  
 
1.1.4.2. Effects of Acetylcholine   
Vasodilation in response to ACh is endothelium-dependent and is mediated by NO, former known 
as the endothelium derived relaxation factor.62,70 If the layer of endothelial cells is removed, dilatory 
responses are abolished and ACh leads to vasoconstriction.89 By binding on a muscarinic receptor 
(M3) located on the endothelial wall, ACh induces complex intracellular mechanisms. The 
phosphatidyl-inositol-pathway is activated and triggers calcium-release and activation of 
calmodulin, which binds to the endothelial NO-synthase (eNOS). Binding of calmodulin results in 
the synthesis of the vasodilating agent NO.90 The enzyme NO-synthase (NOS) converts L-arginine, 
a semi-essential proteinogenic amino-acid, to NO and citrulline.91 As NO is gasiform, it diffuses 
through the cell membrane of the endothelial cell into the smooth muscle cell can there activate the 
soluble guanyl cyclase. The subsequent production of cyclic guanosine-monophosphate (cGMP) 
activates cGMP-dependent protein kinases which effect most of the intracellular actions modulating 
the conductance of potassium channels, leading to hyperpolarisation and finally to relaxation of 
smooth muscle cells.92 Preincubation with L-nitro arginine methylester (L-NAME) abolishes the 
dilatory response by blocking the NOS. Genetic knock-out of the eNOS has the same effect (eNOS-
/- mice).93-95 Besides eNOS, two other isoforms of the enzyme located in various tissues are known, 
the neuronal NOS (nNOS) and the inducible inflammatory NOS (iNOS).74,96 Under certain 
circumstances, ACh leads to endothelium-dependent vasoconstriction. The degree of contraction 
depends on the concentration of ACh (onset from 10-7 mmol/L). Since the exact mechanism of 
contraction is still unsolved, the term of the “endothelium-derived contraction factor” (EDCF) was 
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introduced.97 Subsequent research on the subject proposed several endoperoxide molecules like 
prostaglandin H2,95 thromboxane A2,98 prostaglandin I2,99 prostacyclin100 and isoprostanes101 as 
effectors. Endoperoxides are synthesized by COX and cause vasoconstriction. They can be further 
transformed by specific synthases into molecules like thromboxane, prostaglandins or 
prostacyclin.102 The activation of COX in the endothelium must thus play a key role in the process 
of modified ACh-responsiveness in obesity,103,104 as its inhibition with non-selective COX-inhibitors 
(indomethacin or meclofenamate [Meclo]) abolishes the response.95,105 Knocking out the COX-1 
gene abolishes EDCF-dependent responses, whereas knocking out the COX-2 or its chemical 
inhibition does not block contractile effects.106,107 Thus in mice, COX-1 seems to play a crucial 
role.107 Prostacyclin synthase is upregulated in hypertensive and aged animals108 and causes an 
increased vasoconstriction in these animals.100 The role of thromboxane A2 remains unclear, as 
subsequent studies have shown that thromboxane A2 synthase inhibitor does not affect the EDCF 
response to ACh or even that the addition of thromboxane A2 acts dilatory and abolishes the 
contractile response.100 It was also observed that vasoconstriction in arteries induced by a high-
cholesterol diet can be abolished by a thromboxan A2 receptor antagonist and that contractile 
responses to ACh can be blocked by antagonizing the thromboxan-prostaglandin-receptor or more 
specifically antagonizing the receptor of prostaglandin H2 on the smooth muscle cell layer.95,103,109  
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1.1.5. Heterogeneity of Vascular Beds 
Arteries can be divided in elastic and muscular type based on their microscopic architecture. 
Whereas in elastic type arteries the tunica media contains a large percentage of elastic fibres, in 
muscular type arteries it consists predominantly of smooth muscle fibers. The arteries also show 
differences on molecular level, as in the elastic arteries, vimentin is the major smooth muscle cell 
filament protein, whereas in the muscular arteries both vimentin and desmin are found.110,111 The 
aorta and its direct branches build the group of the elastic type arteries, the more distally located 
conduct vessels are from the muscular type. The aorta and carotid arteries are typical 
representatives of elastic type arteries, whereas the femoral artery belongs to the group of muscular 
arteries. Both groups are though susceptible to atherosclerosis and stiffening with aging.112-114 They 
however differ in their lumen diameter and in the thickness of vascular smooth muscle cell layer. 
The extent of atherosclerotic plaques in the aorta and carotid artery correlates with the extent of 
coronary artery disease.115 Despite these similarities, the impact of the vasomodulator factors differs 
between the vascular beds. The carotid artery is more sensitive to ACh than the femoral artery in 
young C57BL/6J.116 In the carotid artery, the activation of the cGMP-dependent NO-pathway by 
ACh is predominantly responsible for relaxations, whereas in the femoral artery a K-channel-
dependent pathway is involved.116 In young C57BL/6J mice ACh leads to contractions in the carotid 
artery, but not in the femoral artery.116 In eNOS-/- mice, ACh leads to contractions not only in the 
aorta, but also in femoral and carotid arteries.95 Interestingly, in humans, the aorta seems to be more 
susceptible to atherosclerotic changes than the carotid artery.117,118 
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1.2. Aim of the Study 
Obesity is a disease, which has developed epidemic character and thus has become an important 
issue in health care and research. The prevalence of overweight and obesity is rapidly increasing not 
only in adults, but also in children. Obesity in childhood augments the risk of cardiovascular 
morbidity in adulthood. The underlying mechanisms of obesity-mediated changes of vascular 
reactivity have been investigated extensively, but new findings posed new questions, and several 
remain unsolved to this day.  
Given the increasing importance of obesity in youth, the present study was conducted ex vivo using 
aorta and carotid artery from young C57BL/6J mice, an approved rodent model for diet-induced 
obesity. The aim was to investigate, if short-term high-fat diet feeding induces changes in vascular 
reactivity in young mice, and how reaction patterns to different vasoactive agonists vary between 
diet groups and vascular beds. 
 
Main topics of interest were: 
1. The effects of a high dietary fat intake on vascular reactivity in different vascular beds (aorta 
and carotid artery) of young mice 
2. The impact of NO and prostanoids on vascular responsiveness after high-fat diet 
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2. Methods and Materials 
2.1. Animals 
The study was conducted using healthy male mice (C57BL/6J, Charles River, Sulzfeld, Germany). 
Animals were kept at the animal facility of the "Biologisches Zentrallabor" of the University 
Hospital of Zurich. In addition to specified diets, mice were provided tap water ad libitum. The 
animals were exposed to twelve hour light/dark cycle. The room temperature was maintained at 
22°C. Experimental setup and animal accommodation were approved by the "Kommission für 
Tierversuche des Kantons Zürich" Switzerland, the local authority for animal research, and conform 
to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of 
Health (NIH Publication No. 85-23, revised 1996). 
 
2.2. Dietary Treatments 
Mice were either fed a standard chow (12.3% of total kcal from fat, Kliba Nafag 3430, Kaiseraugst, 
Switzerland, referred as Control group) or a high-fat diet (58% of total kcal from fat, Research 
Diets D12331, referred as Obese group). The macronutrient compositions of the diets are reported 
in Table 1. The major source of the lipid fraction of the high-fat diet was derived from coconut oil, 
mostly containing saturated fatty acids (90%).119  
 
Table 1 Major macronutrient constituents of diets given in percent of kcal 
Diet Standard Chow High Fat 
Protein 22.4 16.4 
Carbohydrate 65.4 25.5 
Fat 12.3 58 
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2.3. Groups 
Healthy male C57BL/6J mice of 4 weeks of age were randomly assigned to one of the following 
groups:  - Control: Fed with standard rodent chow for 30 weeks 
- Obese: Fed with high-fat diet for 30 weeks 
 
2.4. Glucose Tolerance Test 
The animals were starved overnight, body weight was measured and venous blood was obtained 
from the tail vein (0 min) for baseline glucose measurement. An AccuChek Advantage glucose 
meter (Roche Diagnostics, Switzerland) was used for this purpose. Blood samples were taken at 5, 
10, 15, 30, 45, 60, 90, and 120 min after the intraperitoneal injection of D-glucose (2 mg/g body 
weight). 
 
2.5. Preparation of the Arteries 
On the day of the experiment, mice were anesthesized with xylazine (100 mg/kg body weight 
[BW]), ketamine (23 mg/kg BW) and acepromazine (3.0 mg/kg BW), all intraperitoneal. When pain 
reflexes (in response to strong pain triggers on the toes) were absent, abdomen and chest were 
opened by laparotomy and medial sternotomy. Subsequently, exsanguination via cardiac puncture 
was performed. Organs were removed and immediately frozen in liquid nitrogen for further 
investigation. Blood vessels were identified, carefully excised and placed in cold (4°C) Krebs-
Ringer bicarbonate solution of pH 7.4. Composition of Krebs buffer (in mmol/L): 118.6 NaCl, 4.7 
KCl, 2.5 CaCl2, 1.2 MgSO4, 25.1 NaHCO3, 1.2 KH2PO4, 0.026 EDTANa2Ca and 10.1 glucose. Under 
a microscope (Olympus SZX9, Volketswil, Switzerland), adherent connective, fat and muscle tissue 
was removed carefully from the arteries with microsurgical instruments. Special care was taken to 
prevent endothelial damage or disturbance of the integrity of the smooth muscle cells during this 
procedure. Vessels were then cut into rings (thoracic aorta 3 mm, carotid artery 2.0 - 2.5 mm).  
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2.6. Vascular Function Experiments 
2.6.1. Organ Chambers 
Vascular rings were mounted onto two tungsten hooks (100 µm diameter) under the microscope. 
The aortic and carotid artery rings were transferred to the water-jacketed pre-warmed organ 
chambers containing aerated (95% O2, 5% CO2) Krebs solutions (pH 7.4, 37°C). Chamber volume 
was 10 ml. The rings were connected to a force transducer (Hugo Sachs, Mach-Hugstetten, 
Germany) that allowed recording of isometric tension via an anchor. Before stretching the vessels, 
an equilibration time of 30 minutes was provided. To achieve an optimal level of passive tension, 
vessels were stretched in a stepwise manner. Optimal stretching weights for aorta and carotid artery 
rings (as investigated in earlier experiments in the laboratory) were for aorta 2.5 g and for carotid 
artery 1.75g. After another equilibration period of 20 minutes, the integrity of the vascular smooth 
muscle cell layer was verified by repeated exposure to potassium chloride (KCl, 100 mmol/L, iso-
osmotically replaced), until a stable response was achieved. Recordings were transferred to an X/Y-
plotter (Rikadenki Electronics, Tokyo, Japan) and printed. 
 
2.6.2. Experimental Protocols 
2.6.2.1. Phenylephrine  
After verifying the integrity of the layer of smooth muscle cells with KCl as described above, the 
aortic and carotid artery rings were thoroughly washed with Krebs buffer. Vascular rings were 
either left untreated or L-NAME (300 µmol/L) was added to the solution in the organ chamber and 
incubated for 30 minutes. Subsequently, PE, an adrenergic α1-receptor agonist, was added in 
cumulative concentrations starting at 0.1 nmol/L and titrated to 50% KCl.  
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2.6.2.2. Acetylcholine 
To measure responses to ACh, vessels were either left untreated, or incubated with the non-selective 
cyclooxygenase inhibitor Meclo (1 µmol/L) or L-NAME (300 µmol/L). After 30 minutes of 
incubation, vessels were precontracted to 50% of the KCl response by using cumulating 
concentrations of PE. Endothelium-dependent response to ACh (0.1 nmol/L - 300 µmol/L) was then 
examined by adding the agonist in a stepwise manner as shown in Fig. 1. 
 
 
Fig. 1: Representation of a typical contraction and relaxation curve of a carotid artery. X correlates to 5 
minutes, Y correlates to 0.25g. Z indicates the direction of the protocol, starting with phenylephrine 0.1 nM 
(10‐10 mol/l). * indicate endothelium‐dependent contractions to ACh. 
 
2.7. Drugs 
Acepromazine (Fatro, Ozzano Emilia, Italy), xylazine (Bayer, Zurich, Switzerland) and ketamine 
(Chassot AG, Bern, Switzerland) were used for anesthesia. Chemicals used for vascular function 
experiments were ACh, PE, Meclo, all obtained from Sigma-Aldrich (Buchs, Switzerland), and L-
NAME (obtained from ALEXIS Biochemicals, Lausen, Switzerland). Drugs were dissolved in 
purified water (Millipore, Volketswil, Switzerland) and diluted with fresh cold Krebs solution to 
attain the concentration needed. Concentrations are expressed as final molar concentration in the 
organ chambers.  
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2.8. Calculations and Statistical Analysis 
The printed charts were manually digitized. The peak of the vascular response to the second 
exposure of potassium chloride (KCl, 100 mmol/L) was taken as reference value for contractions. 
Relaxations were expressed as percentage of precontraction in response to PE. 
For statistical analysis Microsoft Excel for Windows version 2003, StatView for Windows 
version 5.0.1., FitLab and  Prism Graph Pad version 4.0 for Windows were used. A P value 
smaller than 0.05 was considered significant and "n" equals the number of animals, that were used 
for analysis. Two-tailed paired or unpaired Student's t-test, ANOVA for repeated measurements 
followed by Bonferroni's correction, calculations of the AUC and half maximal effective 
concentration (EC50) or pD2 (=-log[EC50]) were used when appropriate for the dataset. The paired t-
test was used to compare data within the same vessel and treatment group. Otherwise, the unpaired 
t-test was used. ANOVA was used to compare reactions to cumulating concentrations of ACh at 
different time points, as were AUC and pD2 as well. 
Values were represented in bar-graphs, line-graphs or tables. To emphasize the difference between 
relaxation and contraction, percentages for relaxations were shown as negative values, whereas 
percentages for contractions were displayed positively. The intervals of the scales were adjusted 
according to the values of the results. 
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3. Results 
3.1. Effect of High-Fat Diet on Weight Gain 
The changes in body weight were monitored throughout the experimental feeding period of 30 
weeks. In Table 2, the absolute weight gain in the Control and Obese group is listed. The gain in 
weight was calculated by subtracting the initial weight, measured before starting the diet, from the 
final weight at 34 weeks of age. Mice of the obese group gained significantly more weight than 
those of the control group of the same age after 30 weeks of high-fat diet.  
 
Weight Gain 
Group  Control  Obese 
Weight gain (g) 
 
13.8 ± 0.7 
 
 
16.4 ± 0.4* 
 
 
Table 2: Weight gain of mice fed with standard rodent chow or high‐fat diet for 30 weeks. 
 * P<0.05 vs. Control. Control: n=10, Obese: n=7. Values represent means ± standard error. 
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3.2. Effect of High-Fat Diet on Glucose Levels 
Blood glucose levels were measured in starved Control and Obese animals and at 5, 10, 15, 30, 45, 
60, 90 and 120 min after intraperitoneal injection of D-glucose (2mg/g body weight), Fig. 2. Before 
the injection, glucose levels were similar. In the Obese group, glucose levels raised markedly higher 
in comparison to the Control group (significant by ANOVA-analysis p<0.05 and the student t-test 
of the AUC values [below in Table 3], final values at 120 min; Control: 7.7±0.4 mmol/L, Obese: 
10.1±0.5 mmol/L). This difference suggests impaired glucose tolerance.  
 
 
Fig. 2: Effect of high‐fat diet on blood glucose levels at 0 to 120 min after intraperitoneal injection of D‐
glucose (2 mg/g body weight) in mice fed a standard chow (Control) or high‐fat diet (Obese) for 30 weeks. 
Control: n=6, Obese: n=16. Values represent means ± standard error. * P<0.05 vs. Control compared by 
ANOVA, and AUC compared by unpaired students t‐test. Values for AUC are represented below. 
 
Area Under the Curve of Blood Glucose Levels after Intraperitoneal D-Glucose Injection in 
Control and Obese Mice 
AUC 
Control   Obese 
1308.8± 31.6  1814.1 ± 53.1* 
 
Table 3: AUC values for blood glucose levels in response to D‐Glucose injection (2mg/g body weight) in 
mice of the Control and Obese group. Values represent means ± standard error and are given in arbitrary 
units. * P<0.05 vs. Control. Values were compared by unpaired student’s t‐test. 
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3.3. Effects of High-Fat Diet on Vascular Function 
3.3.1.  Effect of High-Fat Diet on Response to Phenylephrine 
Treatment with high-fat diet markedly increased PE-dependent contraction in the aorta and carotid 
artery, Fig. 3A and 3B. In the aorta, high-fat diet induced a 14-fold increase in contraction (Control: 
2.6 ± 0.7%; Obese: 35.9 ± 6.5%), Fig. 3A, whereas in the carotid artery, a 16-fold increase was 
observed (Control: 3.3 ± 1.6%; Obese: 53.0 ± 6.9%), Fig. 3B. Additionally, vessels were treated 
with L-NAME to investigate vascular responsiveness in NO-depleted conditions. In the aorta, the 
PE-induced contractile response was further enhanced in the Obese group (1.8-fold versus 
Untreated; 68.0 ± 8.2% vs. 35.9 ± 6.5%) but not in the Control group (1.5 ± 0.4% versus 2.6 ± 
0.7%) Fig. 3C. However, in the carotid artery, depletion of NO had no significant effect on the 
contractile response in either the Obese group (53.0 ± 6.9% vs. 68.5 ± 11.4%) or the Control group 
(3.3 ± 1.6% vs 2.6 ± 1.4%), Fig. 3D.  
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Fig. 3: Contractile responses to PE in aorta and carotid artery rings of mice fed a standard chow (Control) or 
high‐fat diet (Obese) for 30 weeks. Vessels were either left untreated (A and B) or were pretreated with L‐
NAME (300 µmol/L) for 30 min (C and D) before the exposure to PE (10 nmol/L). Data are expressed as a 
percentage of KCl. A: Aorta (Control: n=9, Obese: n=7). *P<0.05 vs. Control. B: Carotid (Control: n=5, Obese: 
n=7). *P<0.05 vs. Control. C: Aorta (Control: n=16, Obese: n=8). *P<0.05 vs. Control, † P <0.05 vs. Obese 
Untreated.  D: Carotid (Control: n=11, Obese: n=5). *P<0.05 vs. Control. Values were compared using the 
paired or unpaired students t‐test, as appropriate.  
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3.3.2. Effect of High-Fat Diet on Response to Acetylcholine  
3.3.2.1. Nitric Oxide-Dependent Relaxation to Acetylcholine 
Nitric-oxide mediated, endothelium-dependent relaxation to ACh was analyzed in aorta and carotid 
artery rings after 30 weeks of high-fat diet. Vascular response was first investigated in presence of 
endoprostanoids (Untreated) as shown in Fig. 4A and B. In the carotid artery, ACh evoked a 
biphasic response, Fig. 4B, which was not seen in the aorta, Fig. 4A. At low concentrations of ACh 
(<100 nmol/l), carotid artery rings showed a relaxation (maximal relaxation at 30nmol: Control: -
83.4 ± 7.1%, Obese: -84.1 ± 4.1%), whereas above this concentration a contractile response was 
observed (final relaxation: Control: -47.3 ± 7.9%, Obese: -50.2 ± 7.4%), which was not present in 
aortic rings (final relaxation percentage: Control: -87.9 ± 2.7%, Obese:  
-89.0 ± 2.1%), Fig. 4A. There was no difference in endothelium-dependent relaxation between 
Control and Obese groups in either the aorta or the carotid artery. To examine whether prostanoids 
are involved in the ACh-dependent response, vessels were pretreated with Meclo (1 µmol/L), a non-
selective COX inhibitor, Fig. 4C and D. While relaxation in the aorta remained similar, the 
concentration-dependent contraction seen in the untreated carotid artery was no longer observed 
(final relaxation Carotid: Control -97.8 ± 2.2%, Obese -99.7 ± 0.3%; Aorta: Control -92.7 ± 2.1%, 
Obese -93.0 ± 2.6%), which manifests as significantly different single concentration-values at 
concentrations of ACh >3 µmol/l for both Carotid Obese and Control groups. When analyzing the 
AUC (Table 4), values differed significantly just between the Obese group of the untreated carotid 
artery compared with the carotid artery incubated with Meclo. The AUC values of the carotid artery 
were significantly higher compared with the aorta in the group treated with Meclo, but not in the 
Untreated groups. The pD2 values for the carotid artery were higher for all groups, indicating that 
the carotid artery was more sensitive to ACh and reached the half maximal relaxation at a lower 
concentration.  
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Fig. 4 Endothelium‐dependent relaxation to ACh in aorta and carotid artery of mice fed a standard chow 
(Control) or high‐fat diet (Obese) for 30 weeks. Vessels were either left untreated (A and B) or were 
pretreated with Meclo (1 µmol/L) for 30 min (C and D). Data are expressed as a percentage of 
precontraction with PE. A: Aorta (Control: n=7, Obese: n=7), B: Carotid artery (Control: n=5, Obese: n=6). 
*P<0.05 vs. Aorta Untreated, † P<0.05 for pD2 vs. Aorta Untreated (both compared by unpaired students t‐
test). C: Aorta (Control: n=6, Obese: n=6), D: Carotid Artery (Control: n=5, Obese: n=6) *P<0.05 vs. Aorta 
Meclo (compared by ANOVA, pD2 and AUC compared by unpaired students t‐test), † P<0.05 for AUC vs. 
Untreated Obese Carotid, compared by paired students t‐test. Values for AUC and pD2 are represented 
below. 
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Area Under the Curve and Half Maximal Effective Concentration of Responses to 
Acetylcholine for Vessels left untreated or preincubated with Meclofenamate 
  Control  Obese 
Treatment  Vessel  AUC  pD2  AUC  pD2 
Aorta  199.7 ± 20.0  7.2 ± 0.2  187.7 ± 12.9  7.1 ± 0.1 
Untreated 
Carotid  218.2 ± 23.0  8.2 ± 0.1*  214.8 ± 23.9  8.2 ± 0.1* 
Aorta  194.0 ± 10.6  7.1 ± 0.1  188.5 ± 18.1  7.1 ± 0.2 
Meclofenamate 
Carotid  279.2 ± 22.4*  7.9 ± 0.2*  307.0 ± 10.0*†  8.1 ± 0.1* 
 
Table 4: AUC and pD2 values for vascular responses to ACh in the aorta and carotid artery, Control and 
Obese groups, vessels in presence or absence of Meclo (1 µmol/L). Values represent means ± standard 
error and are given in arbitrary units for AUC and in mol/l for pD2. * P<0.05 vs. Aorta, † P<0.05 vs. 
untreated Carotid. Values were compared by paired or unpaired student’s t‐test where appropriate. 
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3.3.2.2. Nitric Oxide-Independent Response to Acetylcholine 
To examine the response to ACh in NO-depleted conditions, L-NAME was used. The relaxation 
observed in vessels left untreated or preincubated with meclofenamate (Fig. 4) was blocked after 
pre-treatment with L-NAME (Fig. 5). In the aorta, Fig. 5A, a contractile response starting at 0.3 
µmol/l ACh was seen with no significant difference between the control and obese group (final 
contraction at 30 µmol/l ACh, Aorta: Control: 14.3 ± 1.9%, Obese: 14.5 ± 1.4%). The carotid artery 
rings, Fig. 5B, were more sensitive and showed a contractile response starting at 0.1µmol/l ACh. 
Moreover, in these rings, the contractile response differed between the groups and was enhanced in 
the Obese group as compared with the Control group (final contraction at 30 µmol/l ACh, Carotid: 
Control 31.7 ± 5.8%, Obese 53.7 ± 3.7%). The AUC values were significantly higher in the carotid 
artery in comparison with the aorta for both diet groups (Table 5). Furthermore, AUC values were 
higher in the carotid artery from Obese animals as compared to the Control. The pD2 values were 
higher in the carotid artery, indicating higher sensitivity towards ACh-dependent contraction (Table 
5).   
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Fig. 5  Endothelium‐dependent  contraction  to ACh  in aorta and carotid artery of mice  fed  standard chow 
(Control) or high‐fat diet (Obese) for 30 weeks. Vessels were pretreated with L‐NAME (300 µmol/L) for 30 
min. Data are expressed as a percentage of precontraction with KCl. A: Aorta (Control: n=6, Obese: n=7), B: 
Carotid Artery (Control: n=5, Obese: n=7). *P<0.05 vs. Control Aorta, † P <0.05 vs. Control Carotid Artery, ‡ 
P <0.05 vs. Obese Aorta, compared by ANOVA. 
 
Area under the curve and half maximal effective concentration of responses to Acetylcholine 
for vessels preincubated with L-NAME 
 Control Obese 
Treatment Vessel AUC pD2 AUC pD2 
Aorta 20.5 ± 2.7 6.4 ± 0.04 21.2 ± 2.3 6.5 ± 0.04 
L-NAME 
Carotid 56.7 ± 15.4* 6.7 ± 0.2* 106.1 ± 8.6*† 7.0 ± 0.1* 
 
Table 5: AUC and pD2 values for vascular responses to ACh in the aorta and carotid artery after 
pretreatment with L‐NAME (300 µmol/L). Values represent means ± standard error and are given in 
arbitrary units for AUC and in mol/l for pD2. * P<0.05 vs. Aorta, † P<0.05 vs. Control Carotid Artery.  
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4. Discussion 
4.1. Summary 
The present study was performed to investigate the effect of high dietary fat intake on vascular 
function in the carotid artery and aorta of young mice. Feeding with high-fat diet increased body 
weight and led to glucose intolerance and altered vascular tone regulation.  
In the thoracic aorta and carotid artery vascular contractions to phenylephrine were increased after 
high-fat diet. Inhibition of endogenous NO further increased phenylephrine-dependent contractions 
in aortic rings of the Obese group. Stimulation with ACh evoked endothelium-dependent relaxation. 
Maximal final values for endothelium-dependent, ACh-mediated relaxation were obtained in 
prostanoid-depleted conditions, after inhibiting the endogenous prostanoid synthesis using 
meclofenamate. The values were similar in both groups and remained unaffected by high-fat diet. 
The carotid artery reacted more sensitively to stimulation with ACh. In native carotid artery rings, 
high concentrations of ACh induced endothelium-dependent contractions, which were prostanoid-
dependent. In the absence of endogenous NO, relaxations to ACh were absent and endothelium-
derived contractile responses were observed in both arterial beds instead. These contractions were 
markedly higher in the carotid artery. Interestingly, high-fat diet further increased endothelium-
dependent contractions in the carotid artery, but not in the aorta. Thus, these data suggest that high 
dietary fat intake induces changes in vascular tone leading to an increased contractile response in 
elastic type arteries. The heterogenous results in different arteries indicate that the importance of the 
different pathways regulating the vascular tone varies between vascular beds and is variably 
influenced by high dietary fat intake. 
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4.2. Weight Gain and Glucose tolerance  
In the present study, mice fed with the high-fat diet were significantly heavier and their glucose 
tolerance was markedly impaired compared with the control group fed with standard chow. High 
dietary fat-mediated metabolic changes in C57BL/6J mice are similar to the metabolic syndrome in 
human beings, since they develop diet-induced obesity and consequent insulin resistance and 
dyslipidemia.120-122 These mice are thus an approved rodent model organism for nutritional and 
vascular research.123 In the present study, the mice were sacrificed at 34 weeks of age, which, based 
on their life expectancy (50% survival point is at about 30 months for C57BL/6J mice), relates to 
early adolescence in human.124 An important element contributing to the development of obesity is a 
high caloric diet.2 The typical "western-style" diet is rich in carbohydrates, especially di- and 
oligosaccharides, and lipids, containing mainly saturated fatty acids.123 These diets have been shown 
to promote overweight, that mainly consists of fat tissue located selectively in the mesentery.125 As 
a consequence, metabolic changes like elevated blood pressure,55 altered insulin synthesis and 
sensitivity and imbalance of vascular tone regulation occur.121,126,127 A number of studies have shown 
that saturated fatty acids have an adverse impact on health.128 Effects include enhanced lipid 
storage, a lowered accessibility of the latter once stored and glucose intolerance.129,130 On the other 
hand, polyunsaturated fatty acids can have desirable effects.128 The molecular correlate of these 
effects still remains elusive. Not only lipids, but also other macronutrients such as protein and 
carbohydrate may contribute to the development of obesity.131 A high-fat diet rich in carbohydrates 
and low on proteins supports fast weight gain, whereas a diet low on carbohydrates and rich in 
proteins cannot prevent from weight gain, but keeps blood glucose and insulin resistance low.131 
The diets used in this study contains comparable amounts of protein (22.4% kcal of protein for 
standard chow and 16.4% kcal of protein for high-fat diet), but differs in the composition of lipids 
(12.3% vs. 58%) and carbohydrates (25.5% vs. 65.4%). The major lipid fraction in the high-fat diet 
was derived from coconut oil, which mostly contains saturated fatty acids (90%). Thus, besides the 
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difference of lipid percentage between the diets, the higher intake of saturated fatty acids in the 
Obese group could have had an effect on changes of vascular responsiveness.  
One of the metabolic changes induced by high dietary fat intake is an impaired glucose tolerance. 
Over the last few years, interactions between glucose- and lipid metabolism and diet have been 
investigated in detail.132 Physiologically, in the liver insulin controls the blood glucose levels by 
activating glucose storage by inhibiting gluconeogenesis and glycogenolysis and activating 
glyconeogenesis. Several transmembranal glucose transporters are known, some of them are 
expressed constantly, others (like GLUT4) are induced by hormones like insulin. The expression of 
the glucose transporters varies between tissues.133 Besides the expression of glucose carrier 
molecules, insulin accounts for a variety of regulatory effects in various systems. In the adipose 
tissue, glucose uptake via the GLUT4 pathway is activated by insulin.134 Also in the muscle, which 
accounts for 75% of the stored blood glucose, glucose uptake by GLUT4 transporters is 
enhanced.135 Intracellularly, glucose metabolisation into triglycerides is enhanced, but the reverse 
way (energy mobilisation by lipolysis) is blocked.136 A high dietary fat intake can influence 
metabolism by increased body weight and directly via altered insulin action.129 It is reported that the 
insulin-dependent translocation of the intracellular localised glucose receptor GLUT4 to the cellular 
membrane is reduced in type II diabetes.137 Adiposity is one of the main risk factors for type II 
diabetes.138 The latter is pathophysiologically associated with an insulin insensitivity of metabolic 
organs like the liver, skeletal muscle and the adipose tissue, which leads to glucose intolerance.139 In 
the present study, impaired glucose tolerance and greater weight gain was observed in animals fed a 
high-fat diet. A nuclear receptor involved in this regulation is PPARγ (peroxisome proliferator-
activated receptor γ), a lipid sensor molecule modulating gene expression and thereby survival, 
proliferation and differentiation of different cell types, such as adipocytes.140 It has been 
demonstrated that modulation of agonists binding to PPARγ can prevent cells from pathological 
changes related to obesity and diabetes.141 Specific deletion of PPARγ in mice adipose tissue 
diminishes weight gain and glucose intolerance as a consequence of high-fat diet.142 Oral 
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antidiabetics of the class of glitazones bind to this receptor in order to decrease insulin resistance, 
but can also modify synthesis of vascular endothelial growth factor, leptin, interleukins and 
adiponectin.141,143,144 Another important player in the regulation of metabolism is the appetite-
regulating hormone leptin, which is secreted mainly by fat cells.145 Obesity induced by high-fat diet 
leads to leptin-resistance in peripheral tissues146 and a high saturated-fat diet lowers circulating 
leptin levels.147 Interestingly, knockout of cannabinoid receptors lowers leptin and insulin levels 
similarly, but enhances leptin sensitivity and thus leads to leanness.148 Beside obesity and diabetes, 
C57BL/6J mice fed with high-fat diet also develop increased renal lipid accumulation and 
glomerulosclerosis.149 High-fat diet can also lead to inflammation of intestinal, adipose and liver 
tissue.150 Based on these findings it can be concluded that high-fat diet and obesity do not only 
interact with the complex system of glucose metabolism and body weight homoeostasis, but can 
also induce structural changes in organs, tissues and other regulatory mechanisms.  
 
4.3. Effects of High-Fat Diet on Vascular Tone  
4.3.1. Phenylephrine-Mediated Contractions 
In the present study, vascular contractions to phenylephrine were increased in aorta and carotid 
arteries after high-fat diet. Possible molecular mechanisms of the increased contractile response to 
phenylephrine as an effect of high-fat feeding may be: a) change in receptor expression; b) receptor-
mediated downstream signalling; c) inhibition of anti-contractile factors. In the aorta, the 
contractions were further increased by the blockage of endogenous NO synthesis in the Obese 
group. This suggests that basal NO synthesis is of higher relevance to the balance of contractile and 
relaxing stimuli in mice fed a high-fat diet. 
In the carotid artery, depletion of NO did not further increase PE-mediated contractions, which may 
be due to: a) involvement of effector molecules other than NO, b) maximal contraction, which 
cannot be further increased. The findings of the present study are in line with the data of Molnar et 
al., who fed mice with a high-fat diet for 9 weeks starting at 8 to 10 weeks of age and found 
Discussion 
 29 
enhanced contractile response in femoral arteries.151 Reil et al., examined the effects of a 26 weeks-
high-fat, high-sucrose diet on rat aortas though did not find a change in contractile responses to 
phenyephrine.55 A reason for these contradictory findings could be: a) differences in animal species 
and vascular beds, b) the differences in the constituents of high-fat diet. 
In earlier reported studies, obese mice that were fed a high-fat diet showed increased expression 
levels of vasoconstrictor receptors, leading to various downstream-effects.21 The animals showed 
higher activation of the sympathetic nervous system,127 but reduced adrenergic stimulation of 
lipolysis due to changed expression of their receptors.152 One of the contributing changes was an 
increased ratio of α2 to β-adrenergic receptors.83,153 The expression of β1 and β3 adrenergic receptors 
in C57BL/6J mice fed a high-fat diet is reduced and the β-receptor activated adenylyl cyclase 
activity is diminished in brown and white adipose tissue cells of these mice.152 Details of the 
interactions and the downstream receptor signalling still remain elusive, as even though mice 
lacking all three beta-adrenergic receptors become obese,154 knock-out mice unable to synthesize 
norepinephrine and epinephrine (lack of dopamine beta-hydroxylase gene) do not become obese 
with high-fat diet.82 It can be summarised that adrenergic agonists have important effects not only 
on the regulation of vascular tone, but also on the accumulation of body fat and that their receptor 
expression and distribution can be altered by dietary fat intake. 
The findings of the present study indicate that high-fat diet can induce changes in reactivity to 
adrenergic agents even in young animals.  
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4.3.2. Nitric Oxide-Dependent Responses to Acetylcholine 
In the present study, endothelium-dependent vascular relaxations were examined in the presence of 
ACh in a concentration-dependent manner. The carotid artery was more sensitive to ACh-mediated 
relaxation compared to the aorta. The difference may be attributed to: a) the architecture of the 
vascular ring (e.g. the density of smooth muscle cells), b) the expression level of ACh specific 
receptor, c) differences in the expression or activity of molecules involved in the intracellular 
signalling pathway. 
Maximal vascular relaxation was similar in the two vascular beds and was unaltered by high-fat 
diet. These values were obtained by nullifying the influence of endogenous prostanoids by blocking 
the COX. This finding is contradictory to other studies reporting that vascular relaxation is impaired 
after high-dietary fat intake. Previously published findings in C57BL/6J mice fed a high-fat diet for 
30 weeks had shown a diminished relaxation in the carotid artery of the Obese group.107 Molnar et 
al. found maximal relaxations of only about 25% to ACh in femoral arteries of mice fed a high-fat 
diet for 9 weeks (total age 17 to 19 weeks).151 Reil et al., studied rats fed a high-fat, high-sucrose 
diet for 6 months and found an increase of systemic blood pressure and attenuation of dilatory 
responses to ACh as well.55 In the present study, maximal relaxations to ACh of more than 80% 
were observed in all groups. Several factors may contribute to the differences in ACh-dependent 
relaxations between the numerous studies: a) different age of the animals, b) differences in the 
vascular beds, c) differences in dietary fat composition, d) duration of diet, e) the way in which the 
artery was prepared for the experiment to prevent endothelial injury during the dissection.  
In the present study, the initial endothelium-dependent relaxation was followed by a contractile 
response in the native carotid artery. Treatment with non-selective cyclooxygenase inhibitor 
meclofenamate abolished these endothelium-dependent contractions, thus cyclooxygenase-derived 
endoperoxides are probably involved in the endothelium-mediated contractile responses. In NO-
depleted conditions after treatment with L-NAME, relaxation was blocked and endothelium-
dependent vascular contractions to ACh became more evident in both vascular beds, but varied in 
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intensity. Carotid artery rings showed a stronger contractile response, which was even more 
enhanced in the Obese group. In the aorta, no difference between the groups was observed. This 
suggests that the enhancement of prostaglandin-mediated endothelium-dependent contraction by 
high-fat diet depends on the vascular bed. Previous studies on high-fat diet have also shown that 
endothelium-dependent contractions to ACh are enhanced in pathological states like hypertension, 
diabetes and atherosclerosis in humans.116,155 Vascular inflammation and reduced NO synthesis can 
precede peripheral insulin resistance.156 The dilatory response to ACh is altered by diabetes and the 
influence of the dilatory effectors decreases.105 The presence of so-called EDCFs in vascular 
dysfunction and their dependance on NO synthesis has already been observed by other groups.103,157 
In carotid arteries of ApoE-deficient mice, the synthesis of vasodilating NO is impaired due to 
lower eNOS-activation in response to hypercholesterolemia.158 In the mouse artery, COX-1 seems 
to be involved in mediating endothelium-dependent contraction as inhibition of COX-2 did not 
block the contractile response.107 Moreover, the endothelium-dependent contractions are diminished 
in COX-1 knock-out mice.106 In other animal models, COX-2 derived prostaglandins have been 
shown to mediate endothelium-dependent contractions in the aorta.159  
Furthermore, diet and obesity can alter the synthesis of reactive oxygen species (ROS). Some of 
these molecules, like the superoxide-anion, have the ability to inactivate vasodilating NO promoting 
endothelial dysfunction.160 ROS are suspected to be important mediators of vascular disease.161 
Activation of cholinergic receptors is enhanced in animals fed a high-fat diet. It is coupled to 
increased superoxide anion production and thus suspected to accout for hypercholesterolemia-
induced endothelial dysfunction.158 High glucose levels and maybe even insulin itself (both found in 
animals fed a high-fat diet) can contribute to elevated levels of ROS-production.162 and thus to the 
development of atherosclerosis.163  
Antioxidant drugs or superoxide-dismutase-mimetics abolish abnormal vasoconstriction due to 
cholesterol intake,109,158 supporting the thesis that oxidation and formation of ROS plays a key role 
in the development of endothelial dysfunction.109,164  
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Overall, a tendency to vasoconstriction in consequence of high-fat diet can be observed, but 
changes depend on genetic background, vascular bed and nutritional settings.21,95,165 Even if there are 
no macro- or microscopically detectable atherosclerotic lesions in the vascular system, endothelial 
dysfunction can already be present as a reaction to high dietary fat intake.166  
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4.4. Limitations of the Study and Outlook 
In the present study, numbers of animals are in the range of 5 to 16 per group, which signifies 
limited statistical power. Even with most precaution, mistakes in handling mice, dissecting vessels 
and preparing chemicals used for the study can never be totally excluded.  
To support our findings, it would be interesting to repeat the measurements with higher numbers of 
mice or to know, if other research groups draw the same conclusions using identical dietary 
regimens on mice of the same age and strain. 
Using tissue of the mice sacrificed for the present study, it would be interesting to investigate the 
expression profile of ACh and phenylephrine receptors on endothelial cells and vascular smooth 
muscle cells of arteries. The correlation between the presence of EDCF’s in functional studies and 
the molecular expression profiles could be analyzed.  
As only elastic-type arteries were used to investigate the effects of high-fat diet on vascular tone in 
the present study, it would be interesting to use muscular-type arteries and investigate tissues like 
skeletal muscle, heart muscle, pancreas or liver for changes on macroscopic, microscopic and 
molecular level.  
As a next step, it would be interesting to investigate the reversibility of diet-induced changes in 
regulation of vascular tone by returning to normal diet or increasing physical activity after a period 
of high-fat diet. Furthermore, studies could be conducted on mice of different ages to learn more 
about the influence of age and vascular remodelling due to high-fat diet.  
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4.5. Conclusion and Clinical Implication 
The present study provides evidence for high-fat diet-induced weight gain, glucose intolerance and 
endothelial dysfunction in elastic arteries of obese adolescent mice. The disturbed homeostasis of 
vascular tone manifests as a tendency to vasoconstriction, particularly as an adverse response to 
ACh, which in healthy vessels causes vasodilation.157 The influence of high-fat diet, the importance 
of NO synthesis and the sensitivity to vasoactive molecules vary between different vascular beds. 
The findings of the present study indicate that NO generally plays a more important role in vessels 
of mice fed a high-fat diet, since the inhibition of NO-synthesis enhances contractile responses in 
these animals but not in controls. Moreover, contractions to adrenergic agonists are enhanced in 
obese animals. Reasons could be a stronger activation of the sympathetic nervous system or 
changed receptor expression.127 As a consequence a vicious circle leading to severe dysregulation of 
vessel tone and thus increased systemic resistance develops.  
Endothelium-dependent contractions as a response to ACh  similarly occur in humans.103 Angina 
pectoris occurs, if the myocardial demand of oxygen exceeds the blood supply through the coronary 
arteries.167 Dysregulation of vascular tone can lead to coronary spasms and elicit angina.168 The 
spasms can occur at sites of pre-existing stenosis or totally independently. This form of angina is 
called variant angina pectoris or Prinzmetal-angina. It is a form of angina pectoris which is visible 
in the echocardiogramm, but is entirely reversible and thus does not lead to structural damage.169 
Smoking clearly promotes variant angina pectoris, but it remains unclear, if the other cardiovascular 
risk factors have a correlation.170 In the affected patients, vasospasms can be triggered by activation 
of muscarinic receptors through exposition to ACh.171,172 The molecule presumably responsible for 
the contraction is thus ACh and contractions occur due to pathologic changes in vascular 
reactivity.173 It has been hypothesized that the enhanced contraction could be based on a reduced 
synthesis of NO.174 Symptoms can be alleviated by treatment with nitrates, which liberate NO or 
calcium antagonists.175,176  
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Other studies showed that levels of reactive oxygen species (ROS) are higher in obese animals and 
that ROS degrade NO.67,177 The important role of reactive oxygen in human vascular disease is 
supported by the fact that the endothelial function and symptoms of angina are not just improved by 
treatment with NO-donors, but also with antioxidants.178 Furthermore, the administration of 
cyclooxygenase-inhibitors restores levels of NO and thus improves endothelial function, suggesting 
correlation between enhanced endoprostanoid synthesis and decreased NO levels.179 There is strong 
evidence that the contractions to ACh found in endothelial dysfunction are mediated by endogenous 
prostanoids.100,180 This is supported by the present study as contractions to ACh found in mice fed a 
high-fat diet were blocked by inhibition of COX. The contraction to phenylephrine via alpha-
adrenergic receptors are endothelium-dependent and PKC is one of the molecules in the 
intracellular signalling pathway. As mentioned above, contractions to phenylephrine were stronger 
in mice fed a high-fat diet in the presented study. Interestingly, PKC is upregulated in patients with 
coronary artery spasms.181 Mills et al. found that mice fed a high-fat diet additionally had a stronger 
activation of their sympathetic nervous system.127 Thus, if NO is reduced, ACh paradoxically leads 
to contractions and adrenergic vasoconstrictor stimuli are enhanced, a tendency to vasoconstriction 
becomes perspicuous. Obesity due to high dietary fat intake is a widespread disease and its 
prevalence is still increasing.5,182 It has been shown that childhood obesity in humans affects cardiac 
function already at young age and that it increases the risk of cardiovascular morbidity in adulthood 
and early death.24,25 The finding of the present study that maximal obtained relaxation is unaltered 
suggests, that these changes are not of structural nature, but instead are pure regulatory 
phemonenon. Since it remains unclear, if the observed adverse effects are reversible, reduction of 
risk factors of the metabolic syndrome in sense of primary and secondary prevention should have 
first priority. Improvement of vascular function and regression of correlated risk factors can be 
obtained by dietary restriction and enhanced physical activity.28,183,184 Interventions should be made 
especially at young age to lower the risk for cardiovascular morbidity and also to prevent from 
consecutive cost explosions in the health care sector. If changes have already become symptomatic, 
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efficient therapies for symptom relieve and prevention from aggravation are needed. More detailed 
knowledge about altered signalling pathways in diet-induced obesity like the prostanoid, NO, 
reactive oxygen species synthesis and activity of adrenergic activation could help to improve 
pharmacological interventions. Modulation of the expression, activation and signalling cascade of 
receptors could have effects on body weight, the subsequent metabolic changes and development of 
cardiovascular disease. 
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